Olanzapine
NDC 0093-5245, Olanzapine, tablet, orally disintegrating, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-5245
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077243
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLANZAPINE5 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-5245-65 | 00093524565 | 30 BLISTER PACK in 1 CARTON (0093-5245-65) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0093-5245-19) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/dd0b2525-4e2f-44fc-9302-0ae4ebb1e135NADAC price for package 00093524565
GET /v1/drugs/nadac/00093524565
Use it
Look up 0093-5245 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-5245. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.